Hamilton Lane Advisors’s Cryo-Cell International CCEL Stock Holding History

Hamilton Lane Advisors’s Portfolio CCEL Stock Details CCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-409,734	Closed	-$1.41M	–	21
2025 Q4	$1.41M	Hold	409,734	–	–	0.78%	14
2025 Q3	$1.9M	Hold	409,734	–	–	1.09%	10
2025 Q2	$2.13M	Hold	409,734	–	–	1.57%	6
2025 Q1	$2.61M	Hold	409,734	–	–	2.24%	5
2024 Q4	$3.04M	Hold	409,734	–	–	2.94%	5
2024 Q3	$2.61M	Hold	409,734	–	–	2.26%	6
2024 Q2	$3.12M	Hold	409,734	–	–	2.52%	10
2024 Q1	$3.06M	Hold	409,734	–	–	2.09%	8
2023 Q4	$2.36M	Hold	409,734	–	–	0.97%	11
2023 Q3	$2.16M	Hold	409,734	–	–	1.21%	13
2023 Q2	$2.49M	Hold	409,734	–	–	1.09%	21
2023 Q1	$1.24M	Hold	409,734	–	–	0.41%	26
2022 Q4	$1.73M	Buy	+409,734	New	+$1.96M	0.63%	24

Other funds holding CCEL

SFI Advisors Montclair, New Jersey $95.2M AUM 23.7% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hamilton Lane Advisors's CCEL Position: Q1 2026 in Review

Hamilton Lane Advisors sold out of Cryo-Cell International (CCEL) in Q1 2026, closing a stake of 409,734 shares — an estimated $1.41M sold.

Hamilton Lane Advisors first reported a position in CCEL in Q4 2022 and held it in 13 quarters. The position peaked at $3.12M in Q2 2024. 11 funds tracked by Wall St. Rank hold CCEL as of Q1 2026.

Hamilton Lane Advisors reported no remaining Cryo-Cell International position as of Q1 2026 after selling out during the quarter.
Hamilton Lane Advisors sold 409,734 Cryo-Cell International shares in Q1 2026, an estimated $1.41M.
Hamilton Lane Advisors first reported a position in Cryo-Cell International in Q4 2022 and held it in 13 quarters.
Hamilton Lane Advisors's Cryo-Cell International position peaked at $3.12M in Q2 2024.
11 funds tracked by Wall St. Rank held Cryo-Cell International as of Q1 2026.

Based on Hamilton Lane Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.